Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Plos One
|
February 8, 2013
MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor
Hae Kyung Lee, Ariel Bier, Simona Cazacu, et al.
Neuroradiology
|
May 29, 2019
MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas
Chih-Chun Wu, Rajan Jain, Lucidio Neto, et al.
Journal of Occupational and Environmental Medicine
|
February 17, 2021
Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare Workers
Dee Dee Wang, William W O'Neill, Marcus J Zervos, et al.
Radiology
|
March 21, 2014
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor
Rajan Jain, Laila M Poisson, David Gutman, et al.
Stat (International Statistical Institute)
|
August 23, 2024
A guide to successful management of collaborative partnerships in quantitative research: An illustration of the science of team science
Alyssa Platt, Tracy Truong, Mary Boulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
Sohil H Patel, Laila M Poisson, Daniel J Brat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
Cell Cycle (Georgetown, Tex.)
|
January 26, 2012
Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas
Norman L Lehman, James P O'Donnell, Lisa J Whiteley, et al.
The Journal of Biological Chemistry
|
November 8, 2015
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M Poisson, Hamid Suhail, Jaspreet Singh, et al.
Cell
|
April 7, 2018
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu, Tara Lichtenberg, Katherine A Hoadley, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Plos One
|
February 8, 2013
MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor
Hae Kyung Lee, Ariel Bier, Simona Cazacu, et al.
Neuroradiology
|
May 29, 2019
MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas
Chih-Chun Wu, Rajan Jain, Lucidio Neto, et al.
Journal of Occupational and Environmental Medicine
|
February 17, 2021
Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare Workers
Dee Dee Wang, William W O'Neill, Marcus J Zervos, et al.
Radiology
|
March 21, 2014
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor
Rajan Jain, Laila M Poisson, David Gutman, et al.
Stat (International Statistical Institute)
|
August 23, 2024
A guide to successful management of collaborative partnerships in quantitative research: An illustration of the science of team science
Alyssa Platt, Tracy Truong, Mary Boulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
Sohil H Patel, Laila M Poisson, Daniel J Brat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
Cell Cycle (Georgetown, Tex.)
|
January 26, 2012
Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas
Norman L Lehman, James P O'Donnell, Lisa J Whiteley, et al.
The Journal of Biological Chemistry
|
November 8, 2015
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M Poisson, Hamid Suhail, Jaspreet Singh, et al.
Cell
|
April 7, 2018
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu, Tara Lichtenberg, Katherine A Hoadley, et al.
Page
of 7